News
Holivita from Holiverse uses blockchain-secured data to give users control, enabling personalized preventive healthcare and ...
U.S. President Donald Trump said that tariffs on imported pharmaceuticals can be as much as 250 percent after initially ...
Bourla, who took over as CEO in 2019, has declined to say how long he intends to remain in his role at Pfizer. Developing a ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...
President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.
Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...
Tariffs would disrupt international supply chains, forcing companies to decide whether to pass on increased costs to patients ...
Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...
Pfizer's Albert Bourla told investors that major drugmakers are "ready to to roll up their sleeves" and build out more direct ...
Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other ...
As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results